A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
IntroductionTick-borne encephalitis virus (TBEV) is an important human pathogen that can cause a serious disease involving the central nervous system (tick-borne encephalitis, TBE). Although approved inactivated vaccines are available, the number of TBE cases is rising, and breakthrough infections i...
Main Authors: | Mareike Kubinski, Jana Beicht, Isabel Zdora, Jeannine Biermann, Christina Puff, Thomas Gerlach, Alina Tscherne, Wolfgang Baumgärtner, Albert D. M. E. Osterhaus, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F. Rimmelzwaan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1182963/full |
Similar Items
-
Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice
by: Jana Beicht, et al.
Published: (2023-07-01) -
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection
by: Mareike Kubinski, et al.
Published: (2024-01-01) -
Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection
by: Mareike Kubinski, et al.
Published: (2023-02-01) -
Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise
by: Mareike Kubinski, et al.
Published: (2020-08-01) -
Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity
by: Amare Aregay, et al.
Published: (2024-12-01)